AboutTeamMattersNewsContacts

News



Alexey Mikhailov commented on the newspaper Delovoy Peterburg - Pharmaceutical Prohibition. How pharmaceutical companies defend their patents in court

Date: 25 September 2019

In Russia, billions of rubles are allocated annually for the purchase of medicines for the treatment of different rare diseases. In the market of medical products, both domestic and foreign manufacturers compete. In one of these quiet pharmaceutical wars, luck turned out to be on the side of St. Petersburg's Biocad.

Commentary by Alexey Mikhailov in the article Pharmaceutical Prohibition. How pharmaceutical companies defend their patents in court:

It is rather difficult to judge the prospects of this case, a lot will depend on the results of the forensic examination or the testimonies of the court advisers (if the examination is scheduled). Since the patent is not valid currently, other generic manufacturers can also participate in public procurement - the state allocates a lot of funds and this part of the market becomes attractive for pharmaceutical campaigns. At the same time, the presence of a litigation rather plays into the hands of Biocad, since market players might get the impression that the topic is problematic and that the situation should be clarified.



Thank You!